Viewing Study NCT00337259


Ignite Creation Date: 2025-12-24 @ 2:33 PM
Ignite Modification Date: 2025-12-25 @ 5:49 PM
Study NCT ID: NCT00337259
Status: TERMINATED
Last Update Posted: 2016-02-17
First Post: 2006-06-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Gemcitabine for Marginal Zone Lymphoma
Sponsor: Asan Medical Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module